Skip to main content

Implementing a novel primary care MDT approach with Poole Hospital NHS Foundation Trust Joint Working Project Executive Summary

Improving patient health outcomes through an innovative primary care multi-disciplinary team (MDT) approach, to help address the inequities in achieving the diabetes treatment targets set in NICE Guidelines NG28 and NG17 within Wessex.

A collaborative joint-working project between Poole Hospital NHS Foundation Trust and Boehringer Ingelheim Ltd. 

Diabetes is one of NHS England’s vital clinical priorities with the aim of improving outcomes for people with and at risk of diabetes as part of the wider goal to achieve high quality care for all 1    The National Diabetes Audit (NDA) measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes.2  National Diabetes Audit data support the findings that there are inequities in achieving the diabetes treatment targets within Wessex.  

Poole Hospital NHS Foundation Trust and Boehringer Ingelheim Ltd are undertaking joint working to address inequities and deliver quality improvement through an innovative multidisciplinary team (MDT) primary care approach run across selected localities in 2 STP areas, Dorset and Hampshire & the Isle of Wight. The project aims to improve and sustain attainment of the 3 NICE recommended treatment targets for adults with Type 1 diabetes and adults with Type 2 diabetes:

o HbA1c (glucose control)
o blood pressure
o serum cholesterol

Specifically the joint working project will invest in additional MDT co-ordinator resources to facilitate and sustain the goals of the MDT teams that support GP practices, which will improve the number of people living with diabetes treated to target. Progress and quality improvement in diabetes treatment and care will be tracked by the project team, which will consist of members from Poole Hospital NHS Foundation Trust, Wessex Clinical Networks and Boehringer Ingelheim Ltd. The overall project delivery will be overseen by a project manager.

The project started mid-2019 and will complete at the end of October 2020.

Boehringer Ingelheim Ltd believe they share one fundamental principle with the NHS: putting patients at the heart of everything they do and joint working enables NHS organisations and pharmaceutical companies to work together to improve the health and quality of patients’ lives. 

References:

  1. NHS England. Action for diabetes. Available at: https://www.england.nhs.uk/rightcare/wp-content/uploads/sites/40/2016/08/act-for-diabetes-31-01.pdf Access date: May 2019.

  2. National Diabetes Audit 2017-18 Short Report, Interactive Report England Available at https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-1-care-processes-and-treatment-targets-2017-18-short-report Access date: May 2019.

 

NP-GB-105040    September 2024